Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 36641-36650 Newer>

The Motley Fool June 4, 2009 Morgan Housel	Rebuilding General Motors The New GM, we hear, will be a lean, mean, profitable Motown machine. Therefore, taxpayers' 60.8% ownership stake might be worth something meaningful. Maybe even enough to recoup a significant portion of their investment.
The Motley Fool June 4, 2009 Dan Caplinger	These Stocks Belong in Your Portfolio Enhance your returns by seeking out specialized investments.
The Motley Fool June 4, 2009 Rich Smith	Not Cool, FedEx You can't blame the recession for everything, FedEx. It's time to own up to your mistakes.
On Wall Street June 1, 2009 Gwen Moran	Are Small Caps a Safe Bet? Many may not be well-known or particularly exciting, but small-cap stocks are increasingly getting respect as the way to enjoy big returns and capitalizing on market trends.
Financial Advisor June 2009 Jeff Schlegel	Liquid Investment Water provides an ocean of investing opportunities.
The Motley Fool June 3, 2009 Toby Shute	A Pleasing Oil Patch Pairing Oilfield services player Cameron scoops up NATCO.
The Motley Fool June 3, 2009 Alyce Lomax	The End of the Long Delusion Can we shed delusions in investing, and in our economy? Let's hope so. Otherwise, we're heading for a fall -- just like last time.
The Motley Fool June 3, 2009 Mike Pienciak	Buy Into Inflation Fears at Your Peril Adjusting your portfolio for double-digit inflation could invite more risk than safety.
The Motley Fool June 3, 2009 Christopher Barker	Valero Taps Shareholders ... With a Sledgehammer Valero's move to dilute shareholder equity by almost 8%, announced in the same breath as a massive reduction in second-quarter profit guidance -- from a $0.59-per-share gain to a $0.50 loss -- pains investors like a one-two punch.
The Motley Fool June 3, 2009 Brian Orelli	No More Triple-Digit Returns? If FDA decisions could be predicted easily, investors might not get to enjoy triple-digit returns, so perhaps we shouldn't be too upset about the tight-lipped nature of the FDA.
<Older 36641-36650 Newer> Return to current articles.